Join
Live feed
·
ANALYSTRatingvia Quantisnow
ADMA Biologics Inc logo

Raymond James resumed coverage on ADMA Biologics with a new price target

ByQuantisnow·Wall Street's wire, on your screen.
ADMA· ADMA Biologics Inc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADMA (ADMA Biologics Inc) and more on Quantisnow.

Raymond James resumed coverage on ADMA Biologics with a new price target | Quantisnow